Abstract
Low-dose hCG supplementation was administered at the start of ovarian stimulation, concomitantly with recombinant FSH (rFSH) in GnRH antagonist cycles, and these were compared with GnRH-a cycles that used rFSH alone. The low-dose hCG group had similar implantation and pregnancy rates but had significantly reduced rFSH requirements, allowing for an average cost savings of $600 per cycle.
Original language | English (US) |
---|---|
Pages (from-to) | 1010-1013 |
Number of pages | 4 |
Journal | Fertility and sterility |
Volume | 88 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2007 |
Externally published | Yes |
ASJC Scopus subject areas
- Reproductive Medicine
- Obstetrics and Gynecology